The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize yield, various strategies are employed, including molecular engineering of the host cells and optimization of culture conditions. Additionally, implementation of advanced bioreactors can signi